Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2026-03-01 @ 3:55 PM
Study NCT ID:
NCT02937818
Status:
COMPLETED
Last Update Posted:
2024-06-07
First Post:
2016-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-27
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-05
First Submit QC Date:
None
Study First Post Date:
2016-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-06-16
Results First Submit QC Date:
None
Results First Post Date:
2021-09-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-23
Last Update Post Date:
2024-06-07
Last Update Post Date Type:
ACTUAL